Phase I study to the immunotherapy of metastatic malignant melanoma by a cancer vaccine consisting of autologous cancer cells transfected with the human IL-2 gene

Journal of Molecular Medicine

Volumn 75, Issue 4, 1997, Pages 297-299

  Stingl, G ^a   Brocker, E B ^a   Mertelsmann, R ^a   Wolff, K ^a   Schreiber, S ^a   Kampgen, E ^a   Schneeberger, A ^a   Trcka, J ^a   Brennscheidt, U ^a   Veelken, H ^a   Birnstiel, M L ^a   Zatloukal, K ^a   Maass, G ^a   Wagner, E ^a   Buschle, M ^a   Kempe, E R ^a   Weber, H A ^a   Voigt, T ^a  

^a Universitatsklinik fur Dermatologie   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; INTERLEUKIN 2;

ARTICLE; CANCER CELL; CANCER IMMUNOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG SAFETY; DRUG TOLERABILITY; GENE THERAPY; HUMAN; MELANOMA; PHASE 1 CLINICAL TRIAL;

CANCER VACCINES; CLINICAL PROTOCOLS; HUMANS; IMMUNOTHERAPY, ADOPTIVE; INTERLEUKIN-2; MELANOMA;

EID: 0030951925     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001090050115     Document Type: Article

References (0)